{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T18:27:45Z","timestamp":1771698465952,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22790838"],"award-info":[{"award-number":["22790838"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25290027"],"award-info":[{"award-number":["25290027"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural Research Grants for Neurological and Psychiatric Disorders of NCNP"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16ek0109048h"],"award-info":[{"award-number":["16ek0109048h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.neuint.2019.02.020","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T16:54:57Z","timestamp":1551459297000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Virtual screening identification of novel chemical inhibitors for aberrant interactions between pathogenic mutant SOD1 and tubulin"],"prefix":"10.1016","volume":"126","author":[{"given":"Kazunori","family":"Hirayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-2596","authenticated-orcid":false,"given":"Tomohiro","family":"Kabuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2019.02.020_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000330167","article-title":"Modelling the effects of penetrance and family size on rates of sporadic and familial disease","volume":"71","author":"Al-Chalabi","year":"2011","journal-title":"Hum. Hered."},{"key":"10.1016\/j.neuint.2019.02.020_bib2","first-page":"49","article-title":"The genetics of amyotrophic lateral sclerosis: current insights","volume":"6","author":"Alsultan","year":"2016","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.neuint.2019.02.020_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jns.2011.10.017","article-title":"Misfolded SOD1 forms high-density molecular complexes with synaptic molecules in mutant SOD1-linked familial amyotrophic lateral sclerosis cases","volume":"314","author":"Araki","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuint.2019.02.020_bib4","doi-asserted-by":"crossref","first-page":"15777","DOI":"10.1074\/jbc.M117.789610","article-title":"A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity","volume":"292","author":"Banerjee","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2019.02.020_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/cbdd.13084","article-title":"Aromatic interactions at the ligand-protein interface: implications for the development of docking scoring functions","volume":"91","author":"Brylinski","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.neuint.2019.02.020_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/jnnp-2011-301530","article-title":"Absence of consensus in diagnostic criteria for familial neurodegenerative diseases","volume":"83","author":"Byrne","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuint.2019.02.020_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.drudis.2018.01.027","article-title":"Incorporating upper motor neuron health in ALS drug discovery","volume":"23","author":"Dervishi","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuint.2019.02.020_bib8","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1039\/C6SC01272H","article-title":"The rational design of specific SOD1 inhibitors via copper coordination and their application in ROS signaling research","volume":"7","author":"Dong","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.neuint.2019.02.020_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.nbd.2015.08.010","article-title":"A systematic immunoprecipitation approach reinforces the concept of common conformational alterations in amyotrophic lateral sclerosis-linked SOD1 mutants","volume":"82","author":"Fujisawa","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2019.02.020_bib10","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor-neuron degeneration in mice that express a human Cu,Zn superoxide-dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neuint.2019.02.020_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1093-3263(98)00002-3","article-title":"LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins","volume":"15","author":"Hendlich","year":"1997","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.neuint.2019.02.020_bib12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.neuint.2010.09.010","article-title":"TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase","volume":"57","author":"Higashi","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2019.02.020_bib13","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1016\/j.bmc.2007.07.016","article-title":"Identification of novel chemical inhibitors for ubiquitin C-terminal hydrolase-L3 by virtual screening","volume":"15","author":"Hirayama","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuint.2019.02.020_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuint.2019.02.020_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuint.2019.02.020_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbrc.2009.06.138","article-title":"Familial amyotrophic lateral sclerosis-linked mutant SOD1 aberrantly interacts with tubulin","volume":"387","author":"Kabuta","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2019.02.020_bib17","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1021\/acs.jmedchem.6b01796","article-title":"Discovery of a highly potent, cell-permeable macrocyclic peptidomimetic (MM-589) targeting the WD repeat domain 5 protein (WDR5)-Mixed lineage leukemia (MLL) protein-protein interaction","volume":"60","author":"Karatas","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2019.02.020_bib18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1021\/acs.jcim.7b00455","article-title":"Discovery of novel adenosine receptor antagonists through a combined structure- and ligand-based approach followed by molecular dynamics investigation of ligand binding mode","volume":"58","author":"Lagarias","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.neuint.2019.02.020_bib19","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.bmcl.2003.08.010","article-title":"Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening","volume":"13","author":"McNally","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuint.2019.02.020_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.neuint.2010.01.016","article-title":"Identification of a novel chemical potentiator and inhibitors of UCH-L1 by in silico drug screening","volume":"56","author":"Mitsui","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2019.02.020_bib21","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/brain\/awx082","article-title":"A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK","volume":"140","author":"Morgan","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2019.02.020_bib22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1101\/gad.1640108","article-title":"ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1","volume":"22","author":"Nishitoh","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuint.2019.02.020_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.04.056","article-title":"Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors","volume":"154","author":"Oyallon","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuint.2019.02.020_bib24","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/j.bmcl.2003.08.014","article-title":"Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening","volume":"13","author":"Peng","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuint.2019.02.020_bib25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.neuint.2019.02.020_bib26","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/hmg\/ddp260","article-title":"Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease","volume":"18","author":"Prudencio","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2019.02.020_bib27","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1021\/acs.jmedchem.7b00485","article-title":"Discovery of a small-molecule inhibitor of interleukin 15: pharmacophore-based virtual screening and hit optimization","volume":"60","author":"Quemener","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2019.02.020_bib28","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1021\/acs.jmedchem.8b00330","article-title":"Structure-guided design, synthesis, and characterization of next-generation meprin beta inhibitors","volume":"61","author":"Ramsbeck","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2019.02.020_bib29","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1073\/pnas.0408277102","article-title":"Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation","volume":"102","author":"Ray","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2019.02.020_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng0596-43","article-title":"Motor neurons in Cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury","volume":"13","author":"Reaume","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2019.02.020_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41419-017-0130-4","article-title":"MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS","volume":"9","author":"Shvil","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuint.2019.02.020_bib32","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/hmg\/ddn422","article-title":"Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3","volume":"18","author":"Tateno","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2019.02.020_bib33","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/acs.jcim.5b00747","article-title":"An effective virtual screening protocol to identify promising p53-MDM2 inhibitors","volume":"56","author":"Tortorella","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.neuint.2019.02.020_bib34","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1038\/s41467-018-05127-2","article-title":"A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model","volume":"9","author":"Tsuburaya","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2019.02.020_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10822-018-0102-5","article-title":"Structure-based drug design, synthesis and biological assays of P. falciparum Atg3-Atg8 protein-protein interaction inhibitors","volume":"32","author":"Villa","year":"2018","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.neuint.2019.02.020_bib36","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/acs.jpcb.7b12658","article-title":"Benchmark study based on 2P2IDB to gain insights into the discovery of small-molecule PPI inhibitors","volume":"122","author":"Wang","year":"2018","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.neuint.2019.02.020_bib37","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/acs.jcim.6b00185","article-title":"Discovery of novel inhibitors targeting the menin-mixed lineage leukemia interface using pharmacophore- and docking-based virtual screening","volume":"56","author":"Xu","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.neuint.2019.02.020_bib38","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1021\/acs.jmedchem.7b01455","article-title":"High-affinity peptidomimetic inhibitors of the DCN1-UBC12 protein-protein interaction","volume":"61","author":"Zhou","year":"2018","journal-title":"J. Med. Chem."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618305461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618305461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:44:34Z","timestamp":1759311874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018618305461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":38,"alternative-id":["S0197018618305461"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2019.02.020","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virtual screening identification of novel chemical inhibitors for aberrant interactions between pathogenic mutant SOD1 and tubulin","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2019.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}